Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Caraco Pharmaceutical Laboratories, Ltd.,...

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Caraco Pharmaceutical Laboratories, Ltd. (“Caraco” or the “Company”) (NYSE Amex:CPD) related to the Company’s receipt of a proposal to be acquired by Sun Pharmaceutical Industries Ltd. (“Sun”) and Sun Pharma Global, Inc. (“Sun Global”) in a proposed going-private transaction.

Under the terms of the proposal, Sun, Sun Global, and/or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock not already held by Sun or Sun Global for $4.75 per share in cash. Sun and Sun Global own approximately 75% of Caraco’s outstanding shares. Caraco stock traded above $6.50 per share as recently as August 2010. The investigation concerns possible breaches of fiduciary duty and other violations of law related to consideration of the proposed transaction by Caraco’s board of directors.

If you are a shareholder of Caraco, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at 215-638-4847, Toll Free at 888-638-4847, or by email to [e-mail], or visit our website at http://www.howardsmithlaw.com.